Acta Cryst. (2006). E62, m49-m51  [ doi:10.1107/S1600536805040109 ]

N-[4-Ferrocenyl-5-(1H-1,2,4-triazol-1-yl)-1,3-thiazol-2-yl]-2-nitrobenzamide

L. Shao, X. Zhou, Y. Hu and J.-X. Fang

Abstract: The title compound, [Fe(C₅H₅)(C₁₇H₁₁N₆O₃S)], has been synthesized as a potential anticancer agent. There are two molecules in the asymmetric unit. In the crystal structure, the molecules are associated via N-HN and C-HO interactions.

Online 7 December 2005

Copyright © International Union of Crystallography
IUCr Webmaster